Pharmacological effects and pharmacokinetics of test compounds can be determined in the tumor microenvironment with high sensitivity and temporal resolution by in vivo tumor microdialysis. This technique can be used to determine target engagement and drug penetration of cancer treatments in freely moving syngeneic mouse models and patient derived xenografts (PDX Models).

Tumor Microdialysis as a powerful tool for evaluating cellular signaling within the tumor microenvironment and can help in the development of effective oncology therapeutic strategies. Download our data, and contact us to discuss your project or with any questions you may have at 1.877.CRIVER.1 (1.877.274.8371).